Dr. Nicole J. Rubin, MD

Dr. Rubin practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Rubin's NPI, 1952765489, was assigned on April 11, 2016. Dr. Rubin graduated from University of Connecticut School of Medicine in 2016. Dr. Rubin holds New York license 324370.

Dr. Rubin's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Rubin's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Rubin is also affiliated with Rochester General Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Rubin to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubin practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Rubin's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Rubin's licenses on file in 2 states: New York and California.

CMS data shows 54 Medicare services from Dr. Rubin across 3 procedure codes in 2024, all of them office visits, for 41 Medicare patients. Medicare paid $4,928 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Rubin in 2024. The largest group is 65 to 74, with 22 patients. 66% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rubin's median patient age at 68, with 98% women.

In 2024, Dr. Rubin wrote 104 Medicare Part D claims for 41 patients. 84% of them were for generic drugs. CMS names the drug for 25 of them, across 1 drug with 11 or more claims each, at $297 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Rubin for performance year 2024, reported through an alternative payment model (APM). Dr. Rubin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rubin as offering telehealth. CMS counts 24 procedures of removal of the uterus by Dr. Rubin, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Rubin in 2023. Dr. Rubin's most frequent co-authors are Rebecca Ann Brooks, MD, Anthony Nicholas Karnezis, MD, PhD and Tali Pomerantz.

CMS Open Payments shows 12 general payments to Dr. Rubin from 7 drug and device companies from 2021 to 2025. Education make up the largest share, 52% of the total. Medical Device Business Services, Inc. paid the most, $325.

Dr. Rubin graduated from University of Connecticut School of Medicine in 2016.